Literature DB >> 29297867

Organ transplantation from marginal and non-standard risk donors: ethical requisites for consent from recipients.

Carlo Petrini1.   

Abstract

In order to close the gap between available organs and patients needing transplants, the selection criteria for donors have gradually become more relaxed and many countries have defined expanded criteria for donor variables. However, the use of organs from marginal and non-standard risk donors poses considerable ethical issues. The acceptability of the risk/benefit ratio depends primarily on a clinical assessment, and information given to the recipient and his/her eventual consent are crucial. Some of the requisites concerning information and consent are mandatory. Once these requisites have been defined in binding regulations, adequate margins must be allowed for their personalisation and to account for the unique nature of each physician/patient relationship. Each decision should be specific for a particular person, and it must be accepted that similar clinical situations may give rise to differing solutions that are nonetheless agreed by the physician and the patient.

Entities:  

Mesh:

Year:  2017        PMID: 29297867     DOI: 10.4415/ANN_17_04_13

Source DB:  PubMed          Journal:  Ann Ist Super Sanita        ISSN: 0021-2571            Impact factor:   1.663


  2 in total

1.  The 3-T Model of Informed Consent for Nonstandard Risk Donors: A Proposal for Transplant Clinical Practice.

Authors:  Alessandra Agnese Grossi; Federico Nicoli; Tullia Maria De Feo; Massimo Cardillo; Gabriella Biffa; Renzo Pegoraro; Carlo Petrini; Rosanna Torelli; Francesca Puoti; Giuseppe Rossini; Giuseppe Piccolo; Sergio Vesconi; Enrico Minetti; Barbara Pozzo; Giuseppe Vanacore; David Paredes; Paolo Antonio Grossi; Mario Picozzi
Journal:  Transplant Direct       Date:  2021-10-22

2.  The outcome of kidney transplant from living donors with pelvi-ureteric junction dysfunction.

Authors:  Miroslav Tisljar; Hatem Ali; Charlie Gledhill-Flynn; Mila Garreus; Arvind Ponnusamy; Aimun Ahmed
Journal:  Int Urol Nephrol       Date:  2020-06-10       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.